Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJPS (6) Autor Farias,Mareni Rocha (6) Leite,Silvana Nair (3) Blatt,Carine Raquel (2) Soares,Luciano (2) Storb,Bernd Heinrich (2) Chemello,Clarice (1) Diehl,Eliana Elisabeth (1) Mühlberger,Nikolai (1) Nakamura,Carina Akemi (1) Patricio,Eliziane de Souza (1) Peres,Kaite Cristiane (1) Rosa,Junior André da (1) Siebert,Uwe (1) Silva,Rochele (1) Souza,Fernanda de (1) Storb,Bernd (1) Storpirtis,Silvia (1) Mais... Palavra-chave Community pharmacy (1) Drugs/dispensing practice (1) Effectiveness (1) Health education (1) Health promotion (1) Health services/access (1) Hepatitis C (1) Hepatitis C Chronic (1) Hepatitis C chronic/treatment (1) Hepatitis C/ treatment/cost-effectiveness evaluation (1) Interferon alfa-2a (1) Interferon alfa-2b (1) Interferon alpha/Hepatitis C treatment (1) Parkinson?s disease/treatment (1) Patients/safety (1) Peginterferon alpha/Hepatitis C treatment (1) Pharmaceutical care (1) Pharmaceutical care/scientific production (1) Pharmaceutical service (1) Pharmacists/professional practice (1) Mais... Tipo do documento Info:eu-repo/semantics/article (5) Info:eu-repo/semantics/other (1) Ano 2017 (1) 2014 (3) 2013 (1) 2012 (1) País Brazil (6) Idioma Inglês (6)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 6 Primeira ... 1 ... Última Pharmaceutical services and health promotion: how far have we gone and how are we faring? Scientific output in pharmaceutical studies BJPS Nakamura,Carina Akemi; Soares,Luciano; Farias,Mareni Rocha; Leite,Silvana Nair. The objective of this study was to investigate the scientific output on health promotion within the pharmaceutical field and its relation with the development of pharmaceutical services within health systems. A comprehensive review of published scientific articles from the Medline and Lilacs databases was carried out. The review comprised articles published until December 2011, and used combinations of the terms 'health promotion' or 'health education' and 'pharmacy', 'pharmacist' or 'pharmaceutical'. The articles were selected according to inclusion and exclusion criteria. A total of 170 full texts and 87 indexed abstracts were analyzed, evidencing that most described actions of health promotion in community pharmacies and other services. Following the... Tipo: Info:eu-repo/semantics/article Palavras-chave: Health promotion; Health education; Pharmaceutical care/scientific production; Pharmacists/professional practice; Pharmacy. Ano: 2014 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502014000400773 Pharmaceutical care as a strategy to improve the safety and effectiveness of patients? pharmacotherapy at a pharmacy school: a practical proposal BJPS Chemello,Clarice; Souza,Fernanda de; Patricio,Eliziane de Souza; Farias,Mareni Rocha. Several patients experience at least one drug-related problem and Pharmaceutical Care can change this reality. This work describes a model for structuring the pharmaceutical care service at a pharmacy training unit of the Brazilian Public Health System based on pharmacotherapy follow-up program of Parkinson’s disease patients’ results. From the follow-up results (phase 1), a Therapy Management Scheme was designed (phase 2). Of the 57 patients followed-up, 30 presented at least one drug-related problem and 42% were non-adherent to treatment, which supported the need of pharmacotherapy management. The Pharmacotherapy Management Scheme was proposed as a pharmaceutical care service model, which presents 6 steps: first, the pharmacist fills out the dispensing... Tipo: Info:eu-repo/semantics/article Palavras-chave: Pharmaceutical care; Pharmacotherapy follow-up; Community pharmacy; Patients/safety; Parkinson?s disease/treatment. Ano: 2014 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502014000100019 A model for drug dispensing service based on the care process in the Brazilian health system BJPS Soares,Luciano; Diehl,Eliana Elisabeth; Leite,Silvana Nair; Farias,Mareni Rocha. Access to medication emphasizes the availability of the product at the expense of providing a service. The goal of this paper is to propose a theoretical model for a drug dispensing service, beginning with a reflection on the current realities of the Unified Health System and drug dispensation in Brazil. A conceptual analytical research made by a methodological course called disciplined imagination was mainly the approach applied to develop the model. The drug dispensing service is part of the care process, which considers access as an attribute; reception, connection and accountability, management, and clinical pharmaceutical aspects as components; and the rational use of drugs as the purpose. The proposed model addresses access to the dispensing service... Tipo: Info:eu-repo/semantics/article Palavras-chave: Drugs/dispensing practice; Pharmaceutical service; Unified health system; Health services/access. Ano: 2013 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000100012 Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment BJPS Blatt,Carine Raquel; Storb,Bernd; Mühlberger,Nikolai; Farias,Mareni Rocha; Siebert,Uwe. Brazilian Guidelines to HCV treatment (2007) recommended that the first choice treatment for patients with chronic hepatitis C (CHC) and genotype 2 or 3 is interferon alpha (IFN) plus ribavirin (RBV) for 24 weeks. The aim of this study is compare the cost and effectiveness to Hepatitis C treatment in patients with genotype 2 or 3 of peginterferon alpha (PEG) as the first choice of treatment within PEG for those that do not respond to IFN. The target population is CHC patients with genotype 2 or 3 in Brazil. The interventions are: PEG-SEC (first IFN plus RBV for 24 weeks, after, for non-responders and relapsers subsequently PEG plus RBV for 48 weeks); PEG-FIRST24 (PEG+RBV for 24 weeks). The type of the study is cost-effectiveness analysis. The data sources... Tipo: Info:eu-repo/semantics/article Palavras-chave: Hepatitis C chronic/treatment; Interferon alpha/Hepatitis C treatment; Ribavirin/Hepatitis C treatment; Peginterferon alpha/Hepatitis C treatment; Hepatitis C/ treatment/cost-effectiveness evaluation. Ano: 2014 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502014000200345 Impact Factor: an appropriate criterion for the Qualis journals classification in the Pharmacy area? BJPS Farias,Mareni Rocha; Storb,Bernd Heinrich; Storpirtis,Silvia; Leite,Silvana Nair. Tipo: Info:eu-repo/semantics/other Ano: 2017 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000300101 Sustained virological response to treatment of chronic hepatitis C with peginterferon alfa and ribavirin BJPS Rosa,Junior André da; Blatt,Carine Raquel; Peres,Kaite Cristiane; Storb,Bernd Heinrich; Silva,Rochele; Farias,Mareni Rocha. This study aimed to evaluate the rate of sustained virological response (SVR) and the clinical and treatment characteristics of patients with chronic hepatitis C (CHC). A retrospective uncontrolled cohort study was conducted among patients who received treatment for CHC between 2005 and 2008 attended at the Center for the Application and Monitoring of Injectable Medications, in Florianopolis, SC, Brazil. The inclusion criteria were: patients over 18 years of age, with a confirmed diagnosis of chronic hepatitis C according to Brazilian guidelines, treated with PEG-IFN alfa-2a or 2b associated with RBV. A total of 188 patients were included in the study: 70% men, 59% genotype 1, 27% coinfected with HIV, 31% with cirrhosis. The SVR rate, calculated by... Tipo: Info:eu-repo/semantics/article Palavras-chave: Hepatitis C; Hepatitis C Chronic; Effectiveness; Interferon alfa-2a; Interferon alfa-2b. Ano: 2012 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000200002 Registros recuperados: 6 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco